About BrightEdge Fund
BrightEdge is the American Cancer Society’s donor-funded, philanthropic impact fund. The fund is led by a board comprised of the Society’s leaders and a management team with expertise in investment and venture capital. BrightEdge operates under a charitable fund model that invests in for-profit companies developing novel cancer-focused therapies and technologies. The fund relies on the expertise of the Society’s medical and science professionals to evaluate the mission value of its investments. The fund’s goal is to accelerate delivery of promising cancer-related solutions through capital investment, market awareness and a shared commitment to eradicate cancer.
Investment Details
Investment Range
Not specified
Investment Stage
Various stages
Industry Focus
Finance, Foodtech, Healthcare (+1 more)
Investor Type
Corporate Venture Capital
Investment Focus
Focus Areas
Investment Stages